Stuart Grant
General Counsel presso NUCANA PLC
Profilo
Stuart Grant is currently the Vice President of Regulatory Affairs at NuCana Plc since 2018.
Prior to this, he worked as an Associate Director of Regulatory Affairs at ClinTec International Ltd.
Dr. Grant received his undergraduate and doctorate degrees from the University of Strathclyde.
Posizioni attive di Stuart Grant
| Società | Posizione | Inizio |
|---|---|---|
| NUCANA PLC | General Counsel | 01/09/2018 |
Precedenti posizioni note di Stuart Grant
| Società | Posizione | Fine |
|---|---|---|
ClinTec International Ltd.
 ClinTec International Ltd. Personnel ServicesCommercial Services ClinTec International Ltd. provides clinical research personnel and support services. Its services include full service outsourcing, functional service provider solutions, patient recruitment and retention, education and training, clinical supplies and packaging. The firm offers therapeutics for cardiovascular disease, dermatology, endocrine and metabolic disorders, gastrointestinal disease, genetic disorders, hematology, hepatobiliary, immunology, infectious diseases, nephrology, neurology, nutrition, oncology and orthopedics. The company was founded by Rabinder Buttar in 1997 and is headquartered in Glasgow, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Stuart Grant
| University of Strathclyde | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NUCANA PLC | Health Technology |
| Aziende private | 1 |
|---|---|
ClinTec International Ltd.
ClinTec International Ltd. Personnel ServicesCommercial Services ClinTec International Ltd. provides clinical research personnel and support services. Its services include full service outsourcing, functional service provider solutions, patient recruitment and retention, education and training, clinical supplies and packaging. The firm offers therapeutics for cardiovascular disease, dermatology, endocrine and metabolic disorders, gastrointestinal disease, genetic disorders, hematology, hepatobiliary, immunology, infectious diseases, nephrology, neurology, nutrition, oncology and orthopedics. The company was founded by Rabinder Buttar in 1997 and is headquartered in Glasgow, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Stuart Grant
